Profile
Presently, John Evans occupies the position of Chief Executive Officer & Director at Beam Therapeutics, Inc. and Venture Partner at ARCH Venture Partners LLC. Mr. Evans is also on the board of Verve Therapeutics, Inc.He previously occupied the position of Vice President-Business Development & Operations at Agios Pharmaceuticals, Inc. and Investor Relations Contact at Infinity Pharmaceuticals, Inc.Mr. Evans received a graduate degree from the University of Pennsylvania, an undergraduate degree from Yale University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 1.34% | 2024-06-26 | 1,101,343 ( 1.34% ) | 29 M $ | 2024-08-30 |
Latest news about John Evans
| Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results | GL | |
| Beam Therapeutics Announces Transition of Chief Financial Officer | GL | |
| Beam Therapeutics Insider Sold Shares Worth $1,470,156, According to a Recent SEC Filing | MT | |
| Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) | GL | |
| Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference | GL |
See more
John Evans active positions
| Companies | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Chief Executive Officer | 2016-12-31 |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Chief Executive Officer | - |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Director/Board Member | - |
All active positions of John Evans
Former positions of John Evans
| Companies | Position | End |
|---|---|---|
| PRIME MEDICINE, INC. | Director/Board Member | 2022-09-12 |
| VERVE THERAPEUTICS, INC. | Director/Board Member | 2022-08-03 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 2021-03-30 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-03-31 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 2006-06-30 |
See the detail of John Evans's experience
Training of John Evans
| University of Pennsylvania | Graduate Degree |
| Yale University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Listed companies
Private companies
See the detail of John Evans's experience
Connections
99
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
See the personal network
Linked companies
| Listed companies | 5 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| VERVE THERAPEUTICS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private companies | 4 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Health Technology |
See company connections
